ALLO · Allogene Therapeutics, Inc.
$2.05
+0.07 (+3.54%)
At close · Aug 14
Market Cap
$708.26M
Shares
345.49M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-14 | 20,981 | $1.93 | $40,493 |
| 2026-07-10 | 25,000 | $2.10 | $52,500 |
| 2026-07-09 | 1,858 | $2.12 | $3,939 |
| 2026-07-06 | 1,869 | $2.08 | $3,888 |
| 2026-06-30 | 945,645 | $2.22 | $2,099,332 |
| 2026-06-26 | 1,852 | $2.06 | $3,815 |
| 2026-06-24 | 1,851 | $2.07 | $3,832 |
| 2026-06-17 | 42 | $1.90 | $80 |
| 2026-06-15 | 1,822 | $1.90 | $3,462 |
| 2026-06-09 | 1,871 | $1.85 | $3,461 |
| 2026-06-03 | 1,837 | $2.05 | $3,766 |
| 2026-05-28 | 1,875 | $2.25 | $4,219 |
| 2026-05-26 | 1,802 | $2.00 | $3,604 |
| 2026-05-20 | 1,917 | $1.89 | $3,623 |
| 2026-05-18 | 1,802 | $2.00 | $3,604 |
Showing 1–15 of 15 settlements
Key facts
CIK
1737287
CUSIP
019770106
13F (30d)
203 filings
200 filers
Visit website
Investor relations